SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-103729
Filing Date
2021-04-01
Accepted
2021-04-01 13:24:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d162551dsc13g.htm SC 13G 35636
  Complete submission text file 0001193125-21-103729.txt   37222
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Subject) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90861 | Film No.: 21797272
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35-14, JEYAKGONGDAN 4-GIL HYANGNAM-EUP HWASEONG-SI,GYEONGGI-DO M5 00000
Business Address 35-14, JEYAKGONGDAN 4-GIL HYANGNAM-EUP HWASEONG-SI,GYEONGGI-DO M5 00000 82-10-9496-8579
Daewoong Pharmaceutical Co., Ltd. (Filed by) CIK: 0001854452 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13G